Clinical Trials Browser

Phase 3 × INDUSTRY × sargramostim × Clear all

NCT04229979 2025-10-01

REGAL

Phase 3 Active not recruiting

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT01480479 2018-01-16

ACT IV

Phase 3 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

NCT01265901 2017-10-12

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell

NCT01479244 2017-02-27

PRESENT

Phase 3 Completed

Breast Neoplasms